KDELR2 expression was enhanced in various tumour tissues, including breast cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, colon cancer, bladder cancer and glioblastoma (Figure 1a). This evidence concerns the gene KDELR2 and liver cancer.